MedPage Today December 6, 2022
— Case in point: heart attack survival nationwide
Amid years of Medicare Advantage’s growing popularity, it was increasingly harder to argue that these private plans allow for better care over traditional Medicare, investigators found.
Within the model population of acute myocardial infarction (MI) patients, enrollment in Medicare Advantage was associated with a significant albeit modest reduction in adjusted 30-day mortality rates in 2009 as seen in, for example, people with ST-segment elevation MI (STEMI; 19.1% vs 20.6%).
However, a decade later, improved survival across the board meant that mortality rates no longer favored Medicare Advantage over traditional Medicare (e.g., 17.7% vs 17.8% in STEMI for 2018), according to Bruce Landon, MD, MBA, of Beth Israel Deaconess Medical Center and Harvard...
Today's Sponsors
Today's Sponsor